These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21680807)

  • 21. Colorectal cancer screening practices among obstetrician/gynecologists and nurse practitioners.
    Menees SB; Patel DA; Dalton V
    J Womens Health (Larchmt); 2009 Aug; 18(8):1233-8. PubMed ID: 19630544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early detection of ovarian cancer: new technologies in pursuit of a disease that is neither common nor rare.
    Bast RC
    Trans Am Clin Climatol Assoc; 2004; 115():233-47; discussion 247-8. PubMed ID: 17060970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bilateral oophorectomy in asymptomatic women over 50 years old selected by ovarian cancer screening.
    Hayashi H; Yaginuma Y; Kitamura S; Saitou Y; Miyamoto T; Komori H; Wada K; Ishikawa M
    Gynecol Obstet Invest; 1999; 47(1):58-64. PubMed ID: 9852393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physician knowledge levels and barriers to coronary risk prevention in women: survey results from the Women and Heart Disease Physician Education Initiative.
    Barnhart J; Lewis V; Houghton JL; Charney P
    Womens Health Issues; 2007; 17(2):93-100. PubMed ID: 17403466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian cancer screening in the high-risk population--the UK Familial Ovarian Cancer Screening Study (UKFOCSS).
    Rosenthal AN
    Int J Gynecol Cancer; 2012 May; 22 Suppl 1():S27-8. PubMed ID: 22543917
    [No Abstract]   [Full Text] [Related]  

  • 26. Conflicting and changing breast cancer screening recommendations: survey study of a national sample of ob-gyns after the release of the 2009 USPSTF guidelines.
    Anderson BL; Pearlman M; Griffin J; Schulkin J
    J Healthc Qual; 2013; 35(4):25-35. PubMed ID: 23590634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian cancer screening practices of obstetricians and gynecologists in puerto rico.
    Rodríguez-Ayala G; Romaguera J; López M; Ortiz AP
    Biomed Res Int; 2014; 2014():920915. PubMed ID: 25371904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The incidental postmenopausal adnexal mass.
    McDonald JM; Modesitt SC
    Clin Obstet Gynecol; 2006 Sep; 49(3):506-16. PubMed ID: 16885657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obstetrician-gynecologists' knowledge and opinions about the United States Preventive Services Task Force (USPSTF) committee, the Women's Health Amendment, and the Affordable Care Act: national study after the release of the USPSTF 2009 Breast Cancer Screening Recommendation Statement.
    Anderson BL; Urban RR; Pearlman M; Schulkin J
    Prev Med; 2014 Feb; 59():79-82. PubMed ID: 24246966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement.
    Moyer VA;
    Ann Intern Med; 2012 Dec; 157(12):900-4. PubMed ID: 22964825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early detection and screening for ovarian cancer: does physician specialty matter?
    Brooks SE; Langenberg P; Baquet CR; Moses G; Ghosh A; Khanna N
    J Assoc Acad Minor Phys; 2002 Jul; 13(3):69-75. PubMed ID: 12362563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of a single CA 125 assay combined with ultrasound in the early detection of ovarian and endometrial cancer.
    Vuento MH; Stenman UH; Pirhonen JP; Mäkinen JI; Laippala PJ; Salmi TA
    Gynecol Oncol; 1997 Jan; 64(1):141-6. PubMed ID: 8995563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers and Strategies for Early Detection of Ovarian Cancer.
    Bast RC; Lu Z; Han CY; Lu KH; Anderson KS; Drescher CW; Skates SJ
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2504-2512. PubMed ID: 33051337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian cancer screening: a look at the evidence.
    Fields MM; Chevlen E
    Clin J Oncol Nurs; 2006 Feb; 10(1):77-81. PubMed ID: 16482731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Family physicians' perspectives on ovarian cancer.
    Gray RE; Chart P; Carroll JC; Fitch MI; Cloutier-Fisher D
    Cancer Prev Control; 1999 Feb; 3(1):61-7. PubMed ID: 10474754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comprehensive look at the early detection of ovarian cancer.
    O'Rourke J; Mahon SM
    Clin J Oncol Nurs; 2003; 7(1):41-7. PubMed ID: 12629933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on ovarian cancer screening.
    Munkarah A; Chatterjee M; Tainsky MA
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):22-6. PubMed ID: 17218847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.
    Menon U; Skates SJ; Lewis S; Rosenthal AN; Rufford B; Sibley K; Macdonald N; Dawnay A; Jeyarajah A; Bast RC; Oram D; Jacobs IJ
    J Clin Oncol; 2005 Nov; 23(31):7919-26. PubMed ID: 16258091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Status of tumor markers in ovarian cancer screening.
    Bast RC
    J Clin Oncol; 2003 May; 21(10 Suppl):200s-205s. PubMed ID: 12743135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychological and behavioral impact of receipt of a "normal" ovarian cancer screening test.
    Gaugler JE; Pavlik E; Salsman JM; Andrykowski MA
    Prev Med; 2006 Jun; 42(6):463-70. PubMed ID: 16563482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.